Voyager Therapeutics IncEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 3 USD | 5,55 USD | 2,88 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 14,889 USD | 11 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 60.421.287 | 7,46 | 5,07 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Voyager Therapeutics Inc
Mitarbeiter 141
Handelsplatz NASDAQ
Ticker Symbol VYGR
IPO Datum 2015-11-11
Adresse 75 Hayden Avenue, Lexington, MA, United States, 02421
Webseite https://www.voyagertherapeutics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Alfred W. Sandrock Jr., M.D., Ph.D. | President, CEO & Director |
| 2 | Ms. Robin Swartz | Principal Financial Officer, Treasurer, Chief Business Officer & COO |
| 3 | Dr. Krystof Bankiewicz M.D., Ph.D. | Founder |
| 4 | Dr. Mark A. Kay M.D., Ph.D. | Founder |
| 5 | Ms. Amy Quinlan | Principal Accounting Officer |
| 6 | Mr. Todd Carter Ph.D. | Chief Scientific Officer |
| 7 | Mr. Gregory Shiferman | Senior VP, General Counsel & Secretary |
| 8 | Ms. Trista Morrison | Chief Corporate Affairs Officer & Chief of Staff to the CEO |
| 9 | Dr. Mathieu Nonnenmacher Ph.D. | Vice President of Gene Therapy |
| 10 | Mihalis Kariolis | Vice President of Non-Viral Therapeutics |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Armistice Capital, LLC | 0,00% | 0,00 Mio. USD |
| 3 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 5 | Vestal Point Capital LP | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Opaleye Management Inc | 0,00% | 0,00 Mio. USD |
| 8 | Erste Asset Management GmbH | 0,00% | 0,00 Mio. USD |
| 9 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 10 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 11 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 12 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 14 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 15 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 16 | Sphera Funds Management Ltd. | 0,00% | 0,00 Mio. USD |
| 17 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 18 | Diadema Partners LP | 0,00% | 0,00 Mio. USD |
| 19 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 20 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |